Carlisle et al have shown that high SEPHS2 expression correlates with poor survival in patients with breast carcinoma and that its loss induces glioblastoma cell death by the accumulation of toxic H2Se upon supraphysiological supplementation of sodium selenite (Carlisle et al, 2020). Here, SEPHS2 is linked to breast carcinoma.